Carcinogenesis, Vol 18, 1595-1601, Copyright © 1997 by Oxford University Press
JD Shull, TJ Spady, MC Snyder, SL Johansson and KL Pennington
We have examined the ability of 17beta-estradiol (E2) to induce development
of mammary cancers in the female ACI rat. Continuous treatment with E2,
delivered through release from s.c. Silastic tubing implants containing
27.5 mg crystalline hormone, resulted in rapid development of palpable
mammary tumors in ovary-intact ACI rats. In a population of 21 E2-treated
rats, palpable tumors were first observed following 99 days treatment and
100% of the treated population developed tumors within 197 days. The median
and mean times to appearance of first palpable tumor were 143 and 145 days
respectively. All mammary tumors were classified as carcinomas and invasive
features were observed. Circulating E2 levels in the treated animals at the
time of sacrifice averaged 185 pg/ml serum. Mammary tumors were not
observed in ovary-intact female ACI rats that were not treated with E2.
This is the first report indicating that this naturally occurring estrogen
is capable of inducing mammary cancers in the ACI rat strain. Mammary
carcinoma did not develop in a population of 11 ovariectomized female ACI
rats treated with E2 for a period of 140 days. Circulating E2 levels in the
treated ovariectomized animals averaged 207 pg/ml. These data indicate that
the ovary modulates estrogen-mediated mammary carcinogenesis in this rat
strain. Both ovary-intact and ovariectomized female ACI rats displayed
similar susceptibilities to E2-induced pituitary tumors and
hyperprolactinemia. Pituitary weight was increased 6.0-fold in ovary-intact
ACI rats and 5.3-fold in ovariectomized female rats. Circulating prolactin
levels averaged 2318 ng/ml in E2-treated, ovary-intact rats and 2285 ng/ml
in E2-treated, ovariectomized ACI rats. These data indicate that
estrogen-induced hyperprolactinemia is not the sole factor leading to
development of mammary cancers in the E2- treated ACI rat.
ARTICLES
Ovary-intact, but not ovariectomized female ACI rats treated with 17beta-estradiol rapidly develop mammary carcinoma
Eppley Institute for Research in Cancer and Allied Diseases, Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha 68198-6805, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. G. Kurz, K. K. Hansen, M. T. McLaughlin, V. Shivaswamy, B. S. Schaffer, K. A. Gould, R. D. McComb, J. L. Meza, and J. D. Shull Tissue-Specific Actions of the Ept1, Ept2, Ept6, and Ept9 Genetic Determinants of Responsiveness to Estrogens in the Female Rat Endocrinology, August 1, 2008; 149(8): 3850 - 3859. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Blank, P.-Y. Wong, R. Lakshmanaswamy, R. Guzman, and S. Nandi Both ovarian hormones estrogen and progesterone are necessary for hormonal mammary carcinogenesis in ovariectomized ACI rats PNAS, March 4, 2008; 105(9): 3527 - 3532. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Alkondon, E. F. R. Pereira, M. C. Potter, F. C. Kauffman, R. Schwarcz, and E. X. Albuquerque Strain-Specific Nicotinic Modulation of Glutamatergic Transmission in the CA1 Field of the Rat Hippocampus: August Copenhagen Irish Versus Sprague-Dawley J Neurophysiol, February 1, 2007; 97(2): 1163 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Schaffer, C. M. Lachel, K. L. Pennington, C. R. Murrin, T. E. Strecker, M. Tochacek, K. A. Gould, J. L. Meza, R. D. McComb, and J. D. Shull Genetic Bases of Estrogen-Induced Tumorigenesis in the Rat: Mapping of Loci Controlling Susceptibility to Mammary Cancer in a Brown Norway x ACI Intercross. Cancer Res., August 1, 2006; 66(15): 7793 - 7800. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mesia-Vela, R. I. Sanchez, K. R. Reuhl, A. H. Conney, and F. C. Kauffman Phenobarbital Treatment Inhibits the Formation of Estradiol-Dependent Mammary Tumors in the August-Copenhagen Irish Rat J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 590 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Yager and N. E. Davidson Estrogen Carcinogenesis in Breast Cancer N. Engl. J. Med., January 19, 2006; 354(3): 270 - 282. [Full Text] [PDF] |
||||
![]() |
T. E. Strecker, T. J. Spady, B. S. Schaffer, K. A. Gould, A. E. Kaufman, F. Shen, M. T. McLaughlin, K. L. Pennington, J. L. Meza, and J. D. Shull Genetic Bases of Estrogen-Induced Pituitary Tumorigenesis: Identification of Genetic Loci Determining Estrogen-Induced Pituitary Growth in Reciprocal Crosses Between the ACI and Copenhagen Rat Strains Genetics, April 1, 2005; 169(4): 2189 - 2197. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Gould, M. Tochacek, B. S. Schaffer, T. M. Reindl, C. R. Murrin, C. M. Lachel, E. A. VanderWoude, K. L. Pennington, L. A. Flood, K. K. Bynote, et al. Genetic Determination of Susceptibility to Estrogen-Induced Mammary Cancer in the ACI Rat: Mapping of Emca1 and Emca2 to Chromosomes 5 and 18 Genetics, December 1, 2004; 168(4): 2113 - 2125. [Abstract] [Full Text] [PDF] |
||||
![]() |
V K Turan, R I Sanchez, J J Li, S A Li, K R Reuhl, P E Thomas, A H Conney, M A Gallo, F C Kauffman, and S Mesia-Vela The effects of steroidal estrogens in ACI rat mammary carcinogenesis: 17{beta}-estradiol, 2-hydroxyestradiol, 4-hydroxyestradiol, 16{alpha}-hydroxyestradiol, and 4-hydroxyestrone J. Endocrinol., October 1, 2004; 183(1): 91 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Oomizu, K. Chaturvedi, and D. K. Sarkar Folliculostellate Cells Determine the Susceptibility of Lactotropes to Estradiol's Mitogenic Action Endocrinology, March 1, 2004; 145(3): 1473 - 1480. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Hamilton and T. M. Mack Puberty and Genetic Susceptibility to Breast Cancer in a Case-Control Study in Twins N. Engl. J. Med., June 5, 2003; 348(23): 2313 - 2322. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Bhat, G. Calaf, T. K. Hei, T. Loya, and J. V. Vadgama Critical role of oxidative stress in estrogen-induced carcinogenesis PNAS, April 1, 2003; 100(7): 3913 - 3918. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Hentges and M. J. Low Ovarian Dependence for Pituitary Tumorigenesis in D2 Dopamine Receptor-Deficient Mice Endocrinology, December 1, 2002; 143(12): 4536 - 4543. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mesia-Vela, R. I. Sanchez, J. J. Li, S. A. Li, A. H. Conney, and F. C. Kauffman Catechol estrogen formation in liver microsomes from female ACI and Sprague-Dawley rats: comparison of 2- and 4-hydroxylation revisited Carcinogenesis, August 1, 2002; 23(8): 1369 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M.E Harvell, T. E. Strecker, B. Xie, K. L. Pennington, R. D. McComb, and J. D. Shull Dietary energy restriction inhibits estrogen-induced mammary, but not pituitary, tumorigenesis in the ACI rat Carcinogenesis, January 1, 2002; 23(1): 161 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Shull, K. L. Pennington, T. M. Reindl, M. C. Snyder, T. E. Strecker, T. J. Spady, M. Tochacek, and R. D. McComb Susceptibility to Estrogen-Induced Mammary Cancer Segregates as an Incompletely Dominant Phenotype in Reciprocal Crosses between the ACI and Copenhagen Rat Strains Endocrinology, December 1, 2001; 142(12): 5124 - 5130. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. E. Harvell, T. E. Strecker, B. Xie, L. K. Buckles, M. Tochacek, R. D. McComb, and J. D. Shull Diet-Gene Interactions in Estrogen-Induced Mammary Carcinogenesis in the ACI Rat J. Nutr., November 1, 2001; 131(11): 3087S - 3091. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Wilson and G. A. Reed Predominant 4-hydroxylation of estradiol by constitutive cytochrome P450s in the female ACI rat liver Carcinogenesis, February 1, 2001; 22(2): 257 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ashby Validation of In Vitro and In Vivo Methods for Assessing Endocrine Disrupting Chemicals Toxicol Pathol, May 1, 2000; 28(3): 432 - 437. [Abstract] [PDF] |
||||
![]() |
J. G. Liehr Is Estradiol a Genotoxic Mutagenic Carcinogen? Endocr. Rev., February 1, 2000; 21(1): 40 - 54. [Abstract] [Full Text] |
||||
![]() |
T. J. Spady, K. L. Pennington, R. D. McComb, and J. D. Shull Genetic Bases of Estrogen-Induced Pituitary Growth in an Intercross between the ACI and Copenhagen Rat Strains: Dominant Mendelian Inheritance of the ACI Phenotype Endocrinology, June 1, 1999; 140(6): 2828 - 2835. [Abstract] [Full Text] |
||||
![]() |
T. J. Spady, D. M. E. Harvell, A. Lemus-Wilson, T. E. Strecker, K. L. Pennington, E. A. Vander Woude, D. F. Birt, R. D. McComb, and J. D. Shull Modulation of Estrogen Action in the Rat Pituitary and Mammary Glands by Dietary Energy Consumption J. Nutr., February 1, 1999; 129(2): 587 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. E. Harvell, T. E. Strecker, M. Tochacek, B. Xie, K. L. Pennington, R. D. McComb, S. K. Roy, and J. D. Shull Rat strain-specific actions of 17beta -estradiol in the mammary gland: Correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers PNAS, March 14, 2000; 97(6): 2779 - 2784. [Abstract] [Full Text] [PDF] |
||||











